0709 GMT - Singapore Exchange's multiasset platform can deliver growth visibility, Maybank Research's Thilan Wickramasinghe says in a research report. SGX's derivatives platform is deepening as a regional risk management venue as macroeconomic risks increase and capital rotates to Asia, the analyst says. Also, factors including Singapore's domestic growth and market reforms are intersecting to open a structural pathway for broader equity-market liquidity and capital-raising demand at SGX. Maybank Research lifts its FY 2027-2028 EPS estimates for SGX by 2%-3%. It raises the stock's target price to 28.33 Singapore dollars from S$25.25, with unchanged buy rating. Shares are 0.7% higher at S$24.49.